| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 1.19e-04 | 6 | 57 | 2 | GO:0003726 | |
| Domain | Tyr_kinase_rcpt_2_CS | 4.60e-04 | 11 | 55 | 2 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 5.51e-04 | 12 | 55 | 2 | PS00239 | |
| Domain | ZnF_C2HC | 5.69e-04 | 55 | 55 | 3 | SM00343 | |
| Domain | Znf_CCHC | 5.69e-04 | 55 | 55 | 3 | IPR001878 | |
| Domain | Growth_fac_rcpt_ | 1.15e-03 | 156 | 55 | 4 | IPR009030 | |
| Domain | TyrKc | 2.22e-03 | 88 | 55 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.22e-03 | 88 | 55 | 3 | IPR020635 | |
| Domain | Rho_GTPase_activation_prot | 2.22e-03 | 88 | 55 | 3 | IPR008936 | |
| Domain | JmjC | 2.25e-03 | 24 | 55 | 2 | PF02373 | |
| Domain | PROTEIN_KINASE_TYR | 2.93e-03 | 97 | 55 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.93e-03 | 97 | 55 | 3 | IPR008266 | |
| Domain | Sema | 3.75e-03 | 31 | 55 | 2 | SM00630 | |
| Domain | Semap_dom | 3.75e-03 | 31 | 55 | 2 | IPR001627 | |
| Domain | Sema | 3.75e-03 | 31 | 55 | 2 | PF01403 | |
| Domain | SEMA | 3.75e-03 | 31 | 55 | 2 | PS51004 | |
| Domain | PSI | 3.99e-03 | 32 | 55 | 2 | PF01437 | |
| Domain | JMJC | 3.99e-03 | 32 | 55 | 2 | PS51184 | |
| Domain | Plexin_repeat | 3.99e-03 | 32 | 55 | 2 | IPR002165 | |
| Domain | JmjC_dom | 3.99e-03 | 32 | 55 | 2 | IPR003347 | |
| Domain | JmjC | 4.24e-03 | 33 | 55 | 2 | SM00558 | |
| Domain | Pkinase_Tyr | 6.50e-03 | 129 | 55 | 3 | PF07714 | |
| Domain | PSI | 7.44e-03 | 44 | 55 | 2 | IPR016201 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 7.82e-03 | 138 | 55 | 3 | IPR001245 | |
| Domain | PSI | 8.11e-03 | 46 | 55 | 2 | SM00423 | |
| Pubmed | 6.11e-10 | 25 | 59 | 5 | 17684299 | ||
| Pubmed | 6.45e-08 | 23 | 59 | 4 | 18602769 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TYK2 WIZ SEMA7A LMX1B EXOSC6 TNFAIP3 KDM6B PLXNB2 ABCA7 AHNAK2 HR | 2.19e-06 | 1105 | 59 | 11 | 35748872 |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 30543901 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25827480 | ||
| Pubmed | Structure-function analysis of the A20-binding inhibitor of NF-kappa B activation, ABIN-1. | 2.83e-06 | 2 | 59 | 2 | 12586352 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 12965196 | ||
| Pubmed | TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils. | 2.83e-06 | 2 | 59 | 2 | 26738398 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 28502291 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 29783072 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 26382585 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 32398022 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 25631139 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 29776374 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 20849588 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 10385526 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 22093807 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 22087647 | ||
| Pubmed | 8.48e-06 | 3 | 59 | 2 | 27659348 | ||
| Pubmed | ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB. | 1.69e-05 | 4 | 59 | 2 | 16684768 | |
| Pubmed | Clinical perspectives on lupus genetics: advances and opportunities. | 1.69e-05 | 4 | 59 | 2 | 25034154 | |
| Pubmed | 1.69e-05 | 4 | 59 | 2 | 21266526 | ||
| Pubmed | The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation. | 1.69e-05 | 4 | 59 | 2 | 25165885 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 11389905 | ||
| Pubmed | Intestinal inflammation alters the antigen-specific immune response to a skin commensal. | 2.82e-05 | 5 | 59 | 2 | 35649365 | |
| Pubmed | Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage. | 2.82e-05 | 5 | 59 | 2 | 35077396 | |
| Pubmed | 2.82e-05 | 5 | 59 | 2 | 25264125 | ||
| Pubmed | A20 and ABIN-1 synergistically preserve intestinal epithelial cell survival. | 2.82e-05 | 5 | 59 | 2 | 29930103 | |
| Pubmed | ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. | 4.23e-05 | 6 | 59 | 2 | 21885437 | |
| Pubmed | ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. | 4.23e-05 | 6 | 59 | 2 | 19060883 | |
| Pubmed | 4.23e-05 | 6 | 59 | 2 | 24091983 | ||
| Pubmed | ANKRD13a controls early cell-death checkpoint by interacting with RIP1 independent of NF-κB. | 5.84e-05 | 44 | 59 | 3 | 34839354 | |
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 18270328 | ||
| Pubmed | 5.91e-05 | 7 | 59 | 2 | 15474016 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 29038581 | ||
| Pubmed | 7.87e-05 | 8 | 59 | 2 | 23032186 | ||
| Pubmed | Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis. | 7.87e-05 | 8 | 59 | 2 | 19262574 | |
| Pubmed | delta-Protocadherins: a gene family expressed differentially in the mouse brain. | 1.54e-04 | 11 | 59 | 2 | 15905963 | |
| Pubmed | Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. | 1.54e-04 | 11 | 59 | 2 | 19169254 | |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | 1.77e-04 | 164 | 59 | 4 | 22967998 | |
| Pubmed | 1.85e-04 | 12 | 59 | 2 | 18029035 | ||
| Pubmed | A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. | 1.85e-04 | 12 | 59 | 2 | 35099607 | |
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 30108181 | ||
| Pubmed | 2.18e-04 | 13 | 59 | 2 | 10520995 | ||
| Pubmed | Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse. | 2.54e-04 | 14 | 59 | 2 | 20847152 | |
| Pubmed | 2.93e-04 | 15 | 59 | 2 | 29203883 | ||
| Pubmed | 3.11e-04 | 1293 | 59 | 9 | 15342556 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 3.85e-04 | 364 | 59 | 5 | 24778252 | |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 4.25e-04 | 372 | 59 | 5 | 22939624 | |
| Pubmed | Changes in thyroid status during perinatal development of MCT8-deficient male mice. | 4.25e-04 | 18 | 59 | 2 | 23696569 | |
| Pubmed | 4.25e-04 | 18 | 59 | 2 | 19838193 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.29e-04 | 86 | 59 | 3 | 28327460 | |
| Pubmed | 4.75e-04 | 19 | 59 | 2 | 20953190 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 5.07e-04 | 91 | 59 | 3 | 28558017 | |
| Pubmed | Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip. | 5.74e-04 | 95 | 59 | 3 | 21440680 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.20e-04 | 861 | 59 | 7 | 36931259 | |
| Pubmed | 6.39e-04 | 22 | 59 | 2 | 36098982 | ||
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 6.87e-04 | 101 | 59 | 3 | 20587610 | |
| Pubmed | 7.48e-04 | 104 | 59 | 3 | 9205841 | ||
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 9.27e-04 | 112 | 59 | 3 | 24390342 | |
| Pubmed | 9.66e-04 | 27 | 59 | 2 | 23740937 | ||
| Pubmed | 1.19e-03 | 30 | 59 | 2 | 22837378 | ||
| Pubmed | TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation. | 1.19e-03 | 30 | 59 | 2 | 30420664 | |
| Pubmed | 1.27e-03 | 31 | 59 | 2 | 25996949 | ||
| Pubmed | 1.27e-03 | 31 | 59 | 2 | 27307491 | ||
| Pubmed | HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages. | 1.36e-03 | 32 | 59 | 2 | 27114546 | |
| Pubmed | 1.36e-03 | 32 | 59 | 2 | 19285159 | ||
| Pubmed | 1.49e-03 | 132 | 59 | 3 | 34321664 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.52e-03 | 1005 | 59 | 7 | 19615732 | |
| Pubmed | 1.54e-03 | 496 | 59 | 5 | 31343991 | ||
| Pubmed | 1.62e-03 | 35 | 59 | 2 | 25977363 | ||
| Cytoband | 8p23.1 | 1.72e-06 | 154 | 59 | 5 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 1.32e-05 | 234 | 59 | 5 | chr8p23 | |
| GeneFamily | Non-clustered protocadherins | 2.24e-04 | 12 | 34 | 2 | 21 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.56e-03 | 40 | 34 | 2 | 321 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 7.60e-08 | 20 | 54 | 4 | M1189 | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.40e-07 | 193 | 55 | 6 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-06 | 178 | 55 | 5 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.03e-06 | 193 | 55 | 5 | f22d0a2ea6bbdd625909ccb6a89aca89ab670306 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.03e-06 | 193 | 55 | 5 | dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.49e-05 | 137 | 55 | 4 | a69976938d4e89315ec0be3a332b91ddf3799d65 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 153 | 55 | 4 | 9c3220604b7fa4d91577b6c46960960f49644ca1 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 153 | 55 | 4 | ba624782693b0daa642e50881dbf5f0663fea82d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.56e-05 | 160 | 55 | 4 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.56e-05 | 160 | 55 | 4 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 166 | 55 | 4 | dd5944101ef58a9a29aa3eb5c17690119572b8f1 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 166 | 55 | 4 | 8e5e8de51b4dacdadaa5a08279df30b5c7ed3628 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 5.51e-05 | 168 | 55 | 4 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-05 | 169 | 55 | 4 | 8066b4c02c97d00034802cff2b39799ef44cc904 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.77e-05 | 170 | 55 | 4 | aaf29c2d4de172d366cbfc863bc741941667dde1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.77e-05 | 170 | 55 | 4 | 4d28dc9eb572f43809619f923978cd7494853d43 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-intermediate_monocyte|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.91e-05 | 171 | 55 | 4 | ed5886d6aa87b2d73469d39dc217227bd4d4c918 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-05 | 171 | 55 | 4 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 172 | 55 | 4 | b26fc612f232e8e273825ac2d2e5519cbb7322cf | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-05 | 172 | 55 | 4 | 07bf95ffe77347b4f3159cb88adeaddc1b4796b7 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | 5b76d9cc56bbb29017e64a2d0a3c76c0be003d96 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | bf685025961e79b379f2c35464b6c8ce3e31ace0 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | a6e73a40b0d5356564a594053e772f9d061a5919 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.18e-05 | 173 | 55 | 4 | a8b5370f4c893a20c58e97659f3ac168699693f8 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | 1edef5aeab626cbf2c09468e77b02cfa2d21ba03 | |
| ToppCell | BAL-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.18e-05 | 173 | 55 | 4 | c37dba3804df7c3151e18e6ae4e0b6e7a92bae97 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 174 | 55 | 4 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-05 | 174 | 55 | 4 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.46e-05 | 175 | 55 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | eddac2ba68d234e3f56f4ca0e11c19bc0e95b6e1 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-05 | 176 | 55 | 4 | 1bf8fed48bd224f09efe90a38233b1f01d7311fe | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-05 | 176 | 55 | 4 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.60e-05 | 176 | 55 | 4 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | Severe_COVID-19-Myeloid-Neutrophil|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.75e-05 | 177 | 55 | 4 | a6fae376f1beb1df423484d9b1bd1d954ca117af | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 7.68e-05 | 183 | 55 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.68e-05 | 183 | 55 | 4 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.85e-05 | 184 | 55 | 4 | 857ca1fc4de07b300839b22924211dc624453841 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-05 | 187 | 55 | 4 | 98026c1aaf8de280470ad75536121357934fc78d | |
| ToppCell | 10x5'-Lung-Mast|Lung / Manually curated celltypes from each tissue | 8.35e-05 | 187 | 55 | 4 | f8ac5ca5cbe9c6f3d8c0fffc20fe08ca1aea43c0 | |
| ToppCell | 10x5'-Lung-Mast-Mast_cells|Lung / Manually curated celltypes from each tissue | 8.35e-05 | 187 | 55 | 4 | da275d2c774b3e6a8ed77f777dd0676ecf2ddd2c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.52e-05 | 188 | 55 | 4 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.52e-05 | 188 | 55 | 4 | b4d695c373195d389e0a579e9589e87433286b24 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.52e-05 | 188 | 55 | 4 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 8.70e-05 | 189 | 55 | 4 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 190 | 55 | 4 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.88e-05 | 190 | 55 | 4 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.88e-05 | 190 | 55 | 4 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.06e-05 | 191 | 55 | 4 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 191 | 55 | 4 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | 390C-Myeloid-Mast_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-05 | 191 | 55 | 4 | 88bcd0b85b2112cef15c9e44d1429f9fba4a3400 | |
| ToppCell | 390C-Myeloid-Mast_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.06e-05 | 191 | 55 | 4 | c1517ea7b10a7f732725b4c0224fbfecae80d18b | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.43e-05 | 193 | 55 | 4 | 837c61408462c519912ecf3b83fdc72cd85fe88f | |
| ToppCell | Control-Myeloid-MoAM3|Control / Disease group,lineage and cell class (2021.01.30) | 9.43e-05 | 193 | 55 | 4 | 97d2f12be43fc26efa84ac4c6119132928a123de | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.43e-05 | 193 | 55 | 4 | d81840e1322507552b7726bf7828309375162324 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.43e-05 | 193 | 55 | 4 | e4ca3a3c2704cdc52e6ac3f25f14debf74226c29 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.43e-05 | 193 | 55 | 4 | e54f8b6381b5a96758cff41ab12d6f60cfca29a9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.43e-05 | 193 | 55 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | medial-2-Hematologic-Basophil/Mast_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | 54d33508ce35b3d214214e4efbbb62f358667105 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 9.62e-05 | 194 | 55 | 4 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.62e-05 | 194 | 55 | 4 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | tumor_Lung|World / Location, Cell class and cell subclass | 9.62e-05 | 194 | 55 | 4 | 7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.62e-05 | 194 | 55 | 4 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | medial-Hematologic-Basophil/Mast_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | a89a03d4adebb9f644c27e199bff267180d8ef18 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.62e-05 | 194 | 55 | 4 | 37803f4abf1aa1ad771c9cd293933003d7101e70 | |
| ToppCell | medial-Hematologic-Basophil/Mast_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.62e-05 | 194 | 55 | 4 | ccfc142fe10b4ba16f3036f3f352983ee3e9c8ec | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.62e-05 | 194 | 55 | 4 | d2f6c8900b5c448eede8047ca964e94b19bd6ca5 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.82e-05 | 195 | 55 | 4 | 98a21f5e27d98384b3086034bd6f83441e2e4ef9 | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 9.82e-05 | 195 | 55 | 4 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Microglia/Mac|metastatic_Brain / Location, Cell class and cell subclass | 9.82e-05 | 195 | 55 | 4 | ae48d493ebda5f87781181a3d1d73d8f84fc5e77 | |
| ToppCell | distal-Hematologic-Basophil/Mast_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.82e-05 | 195 | 55 | 4 | 4f83449fce3717518e2acbba1a4b3bea765c0bdb | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.82e-05 | 195 | 55 | 4 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 196 | 55 | 4 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.00e-04 | 196 | 55 | 4 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.02e-04 | 197 | 55 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 197 | 55 | 4 | 0c059476a8cdc6ac71a01d9c414295177f45f8de | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 197 | 55 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | Sigmoid-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.04e-04 | 198 | 55 | 4 | e2d2f9f209f77d0c48cfe3e9902c0ae0795511b2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 198 | 55 | 4 | 4b6767bd6fd4bd43eed18fd4a34c20923fa795da | |
| ToppCell | 3'-GW_trimst-2|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | cf9861bc14737f2dc72e50222159e0180a6d3e5c | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-04 | 198 | 55 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 198 | 55 | 4 | 18daf83309813f914b17bd226ea8a9269a26b107 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-04 | 198 | 55 | 4 | 72c7474e084d1334a09c0a3b0f3c3137038794c8 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-04 | 198 | 55 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 198 | 55 | 4 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.04e-04 | 198 | 55 | 4 | a1247a5efd92f95c6227c0e71dc8a0427eb54b7f | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CCL|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 52c06fcc112da21b1d914a896c04bde06fc756fe | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.06e-04 | 199 | 55 | 4 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | a13f4b8a039304e685464cc8879659824cad5a3e | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.06e-04 | 199 | 55 | 4 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | 15-Trachea-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 1.06e-04 | 199 | 55 | 4 | e0099aa95cf3ec08d7688cc97f4b917fce65a7a3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 199 | 55 | 4 | eeb7d370d4dfacf705306c72ccc4919ddefacff1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CCL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | 51be0e3a91d1f25454b56d55ef6342ef8e8df4e8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 199 | 55 | 4 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 199 | 55 | 4 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 199 | 55 | 4 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | Kidney-Endothelial|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.06e-04 | 199 | 55 | 4 | b543f0686522df43737e9ffa5c9733e42b8a9f4d | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.06e-04 | 199 | 55 | 4 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | normal_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.08e-04 | 200 | 55 | 4 | 6d8f6a6b3f61c529fbed1376659641030abf4f2c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.12e-04 | 48 | 30 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Disease | psoriatic arthritis | 1.27e-08 | 87 | 54 | 6 | EFO_0003778 | |
| Disease | psoriasis vulgaris | 4.84e-06 | 61 | 54 | 4 | EFO_1001494 | |
| Disease | psoriasis, type 2 diabetes mellitus | 1.11e-05 | 75 | 54 | 4 | EFO_0000676, MONDO_0005148 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 4.67e-05 | 38 | 54 | 3 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | respiratory system disease | 1.46e-04 | 145 | 54 | 4 | EFO_0000684 | |
| Disease | Psoriasis | 1.58e-04 | 57 | 54 | 3 | C0033860 | |
| Disease | Pustulosis of Palms and Soles | 1.58e-04 | 57 | 54 | 3 | C0030246 | |
| Disease | late-onset Alzheimers disease | 1.95e-04 | 292 | 54 | 5 | EFO_1001870 | |
| Disease | Sjogren's Syndrome | 2.53e-04 | 13 | 54 | 2 | C1527336 | |
| Disease | Sicca Syndrome | 2.53e-04 | 13 | 54 | 2 | C0086981 | |
| Disease | autoimmune disease | 2.87e-04 | 173 | 54 | 4 | EFO_0005140 | |
| Disease | cutaneous psoriasis measurement, psoriasis | 3.88e-04 | 16 | 54 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | systemic lupus erythematosus | 6.09e-04 | 799 | 54 | 7 | MONDO_0007915 | |
| Disease | coagulation factor V measurement | 6.12e-04 | 20 | 54 | 2 | EFO_0008087 | |
| Disease | basophil count, eosinophil count | 9.96e-04 | 241 | 54 | 4 | EFO_0004842, EFO_0005090 | |
| Disease | transforming growth factor beta measurement | 1.12e-03 | 27 | 54 | 2 | EFO_0004818 | |
| Disease | Squamous cell carcinoma of lung | 1.57e-03 | 32 | 54 | 2 | C0149782 | |
| Disease | psoriasis | 1.58e-03 | 273 | 54 | 4 | EFO_0000676 | |
| Disease | bullous pemphigoid | 1.78e-03 | 34 | 54 | 2 | EFO_0007187 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KPRMDQRPGEGHAFS | 366 | Q96MC4 | |
| EPMRHNLGGNLGDPR | 316 | Q08345 | |
| GPAADPLHQAMRAAG | 36 | Q92843 | |
| DQEPRVTEHRMGPGL | 81 | Q8N6Q3 | |
| DEGRRQPRPGGRDHM | 356 | Q8IZY2 | |
| QPRPGGRDHMEALRS | 361 | Q8IZY2 | |
| ARRSDMDRPEGPGEE | 41 | Q2M1V0 | |
| DIQMPGHAPGRARRT | 341 | Q9NS39 | |
| DMRGQQEREGPGRDH | 601 | Q9Y4B5 | |
| AAADMPQPAVRHQGR | 206 | A8MXZ1 | |
| PFDDRHPGRADPECM | 56 | Q9Y4B6 | |
| RAERQPVEPHMGVGR | 91 | Q9BYH8 | |
| RESDPVRGPDGRMHG | 241 | Q9NQ38 | |
| MPGDHRRIRGPEESQ | 1 | Q5RKV6 | |
| PHGIRMQPCERSAAG | 116 | Q6ZT52 | |
| MHRAVDPPGARAARE | 1 | O15054 | |
| GEAERPSLHQRDGEM | 241 | O43593 | |
| AAADMPQPAVRHQGR | 206 | P0C7W9 | |
| PNPEDGIVRAHMEDS | 651 | O15031 | |
| EEAARGAGPRPNMFD | 806 | O95206 | |
| PEMRQESEQGPCRRH | 181 | P24593 | |
| QARPSRGDSPIMEEH | 1331 | Q9BZA7 | |
| AAADMPQPAVRHQGR | 206 | P0DV76 | |
| EQALDSPRGMHRDGN | 541 | Q86Y26 | |
| MHPGGGPSRAERLEL | 1 | Q86VX9 | |
| GADMDPNPRAALERQ | 96 | Q9BQY9 | |
| GPRPGRGDMEQNDSD | 306 | Q9UN86 | |
| PDPNTMGGASHRDRA | 2536 | O15021 | |
| FARTMPHREADGIPG | 806 | P14616 | |
| PHGMEGALPNREDRA | 561 | Q9BXX0 | |
| QLPKPRMLRESGHGD | 81 | Q969F0 | |
| DTNPDLLRHMPTDRG | 81 | Q8TDG4 | |
| LLRHMPTDRGVGDQP | 86 | Q8TDG4 | |
| MADPGNRGGIHRPLS | 1 | A0A1B0GTK4 | |
| AAADMPQPAVRHQGR | 206 | A8MXJ8 | |
| GERAEPMESCRPGQH | 616 | Q8IX30 | |
| GMEPHRAAGPLQLRF | 16 | P20618 | |
| AAADMPQPAVRHQGR | 206 | P0C7X0 | |
| TEPMEPARSAHRGGE | 16 | Q8N9I5 | |
| GQPRGERELPNSHSM | 416 | Q6ZVC0 | |
| QNGTDHRLPRMAGPG | 536 | A6ND36 | |
| NARPMTDGRATEEHP | 766 | A6ND36 | |
| MHDLPPDSGARRGGR | 1 | Q5VT97 | |
| DRHAPPGKRTVGDQM | 46 | O94906 | |
| AAADMPQPAVRHEGR | 206 | A8MX19 | |
| AAADMPQPAVRHQGR | 206 | A6NNJ1 | |
| AAADMPQPAVRHQGR | 206 | P0C7W8 | |
| GILEPHGGRSDMDRE | 906 | Q9BQS7 | |
| MSQHRRAPGQEPPAD | 286 | O95785 | |
| MNRAENGGRPPHHPF | 56 | Q9BQB4 | |
| RDFPGRPMGHLSKDV | 71 | Q96QB1 | |
| AAADMPQPAVRHQGR | 206 | P0C7V4 | |
| GHPENRDMPASEDLQ | 256 | P49908 | |
| IHMDLPPERDGEKGR | 5001 | Q8IVF2 | |
| ERMAVPAGAQAHPDD | 246 | Q96LP6 | |
| HANAMALGPLPREDG | 141 | Q15025 | |
| ALGPLPREDGNLMLH | 146 | Q15025 | |
| GRRPHRPFEEAAGNM | 141 | Q5SV17 | |
| MAQAPADPGREGHLE | 1 | Q9H171 | |
| REDGSAGPRHLPSMA | 221 | Q9H171 | |
| EQGRREGHAQNPMEP | 361 | P21580 | |
| FQLRMRVPEGPGAHE | 991 | P22105 | |
| ADRHPEVAQRVEPMG | 381 | O75326 | |
| HEEFPLDGRNAPMER | 1201 | P49750 | |
| MDDEDPLVPGRDRGQ | 621 | P29597 | |
| AAADMPQPAVRHQGR | 206 | P0DV75 | |
| DGIKMEEHALRPGPA | 26 | O60663 | |
| TDLHRPLHDEMPGNR | 76 | Q92802 | |
| PAGDPAAGERHRMGR | 6 | Q8N9H8 |